arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

ACCURAY INC

ARAY
$0.29 0.00 (+1.75%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
65 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
38
Health
Weak
Bearish
auto_awesome

Analytical Summary

ACCURAY INC faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth -7.4%
Op. Margin -8.7%
ROIC -5.1%
FCF / Share $-48.86
Trailing P/E
Price / Book 0.8x
FCF Yield
Debt / Equity 3.48
info Valuation on last close. End-of-day price, Aug 7, 2026.

65-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$104.84M
↓ -7.4%
Net Income Profit after all expenses
$-21.68M
↓ -448.3%
Operating Margin Operating profit as % of sales
-8.7%
↑ +23.4% 33th
FCF / Share Free cash flow per share
$-48.86
↑ +68.9%
Long-Term Debt Long-term obligations
$145.18M
↑ +6.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability
29
Returns
41
Financial Health
32
Cash Quality
60

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 65 quarters